Cohort plc (LON:CHRT – Get Free Report) insider Andrew Stephen Thomis bought 2,797 shares of the company’s stock in a transaction on Friday, April 12th. The stock was purchased at an average cost of GBX 715 ($8.90) per share, with a total value of £19,998.55 ($24,895.49).
Andrew Stephen Thomis also recently made the following trade(s):
- On Monday, April 8th, Andrew Stephen Thomis bought 2,753 shares of Cohort stock. The stock was purchased at an average cost of GBX 727 ($9.05) per share, with a total value of £20,014.31 ($24,915.11).
- On Wednesday, March 27th, Andrew Stephen Thomis sold 2,944 shares of Cohort stock. The shares were sold at an average price of GBX 680 ($8.47), for a total value of £20,019.20 ($24,921.20).
Cohort Stock Performance
Shares of CHRT opened at GBX 748 ($9.31) on Wednesday. The stock has a 50-day simple moving average of GBX 609.08 and a 200-day simple moving average of GBX 552.47. The company has a debt-to-equity ratio of 32.14, a quick ratio of 0.93 and a current ratio of 1.69. The stock has a market capitalization of £310.64 million, a PE ratio of 2,266.67 and a beta of 0.53. Cohort plc has a 1 year low of GBX 410 ($5.10) and a 1 year high of GBX 768 ($9.56).
Cohort Cuts Dividend
Analyst Upgrades and Downgrades
Separately, Shore Capital reaffirmed a “buy” rating on shares of Cohort in a research report on Thursday, March 28th.
Check Out Our Latest Research Report on CHRT
Cohort Company Profile
Cohort plc, through its subsidiaries, provides various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and the Asia Pacific and Africa. The company offers electro-optical and electro-mechanical systems, such as command, control, communications, computers, intelligence, surveillance, target acquisition, and reconnaissance, as well as combat systems; and communications systems.
Featured Stories
- Five stocks we like better than Cohort
- Energy and Oil Stocks Explained
- Silicon Motion Proves That AI in Motion Stays in Motion
- What Are Dividends? Buy the Best Dividend Stocks
- Undervalued UnitedHealth Group Won’t Be For Long
- What Investors Need to Know to Beat the Market
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for Cohort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cohort and related companies with MarketBeat.com's FREE daily email newsletter.